MAFAflibercept (Eylea) Injection, Prefilled Syringe 2 mg/0.05 mL
1) Treatment of adults with visual impairment due to neovascular (wet) age-related macular degeneration.
2) Treatment of adults with visual impairment due to diabetic macular oedema.
3) Treatment of adults with visual impairment due to macular oedema secondary to retinal vein occlusion.
4) Treatment of adults with visual impairment due to myopic choroidal neovascularisation.